Bioequivalence studies in drug development: Methods and applications

被引：0
|
作者：
Longford, N. T. [1 ,2 ]
机构：
[1] SNTL, Barcelona, Spain
[2] Univ Pompeu Fabra, Barcelona, Spain
来源：
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY | 2008年 / 171卷
关键词：
D O I：
10.1111/j.1467-985X.2008.00561_8.x
中图分类号：
O1 [数学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 0701 ; 070101 ;
摘要：
引用
收藏
页码：1037 / 1037
页数：1
相关论文
共 50 条
  • [41] Increasing impact of quantitative methods and modeling in establishment of bioequivalence and characterization of drug delivery
    Yoon, Miyoung
    Babiskin, Andrew
    Hu, Meng
    Wu, Fang
    Raney, Sam G.
    Fang, Lanyan
    Zhao, Liang
    [J]. CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2023, 12 (05): : 552 - 555
  • [42] Common Deficiencies with Bioequivalence Submissions in Abbreviated New Drug Applications Assessed by FDA
    Qing Liu
    Barbara M. Davit
    Svetlana A. Cherstniakova
    Suman Dandamudi
    Johnetta F. Walters
    Christina H. Lee
    Kimberly W. Raines
    Ke Ren
    Leeh N. Williamson
    Dale P. Conner
    [J]. The AAPS Journal, 2012, 14 : 19 - 22
  • [43] STATISTICAL-ANALYSIS OF PHARMACOKINETIC DATA WITH SPECIAL APPLICATIONS TO BIOEQUIVALENCE STUDIES
    POWERS, J
    POWERS, T
    [J]. ANNALES DE RECHERCHES VETERINAIRES, 1990, 21 : S87 - S92
  • [44] ANALYTICAL METHODS VALIDATION - BIOAVAILABILITY, BIOEQUIVALENCE AND PHARMACOKINETIC STUDIES - CONFERENCE REPORT
    SHAH, VP
    MIDHA, KK
    DIGHE, S
    MCGILVERAY, IJ
    SKELLY, JP
    YACOBI, A
    LAYLOFF, T
    VISWANATHAN, CT
    COOK, CE
    MCDOWALL, RD
    PITTMAN, KA
    SPECTOR, S
    ALBERT, KS
    BOLTON, S
    DOBRINSKA, M
    DOUB, W
    EICHELBAUM, M
    FINDLAY, JWA
    GALLICANO, K
    GARLAND, W
    HARDY, DJ
    HULSE, JD
    KARNES, HT
    LANGE, R
    MASON, WD
    MCKAY, G
    ORMSBY, E
    OVERPECK, J
    PLATTENBERG, HD
    SHIU, G
    SITAR, D
    SORGEL, F
    STEWART, JT
    VISWANATHAN, CT
    YUH, L
    [J]. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1991, 16 (04) : 249 - 255
  • [45] Common Deficiencies with Bioequivalence Submissions in Abbreviated New Drug Applications Assessed by FDA
    Liu, Qing
    Davit, Barbara M.
    Cherstniakova, Svetlana A.
    Dandamudi, Suman
    Walters, Johnetta F.
    Lee, Christina H.
    Raines, Kimberly W.
    Ren, Ke
    Williamson, Leeh N.
    Conner, Dale P.
    [J]. AAPS JOURNAL, 2012, 14 (01): : 19 - 22
  • [46] Eyeing opthalmic products: Bioequivalence assessment and drug development - Strategic considerations
    Srinivas, Nuggehally R.
    [J]. ASIAN JOURNAL OF PHARMACEUTICS, 2009, 3 (02)
  • [47] FAILURE OF STATISTICAL METHODS TO PROVE BIOEQUIVALENCE OF MELOXICAM DRUG PRODUCTS. I. PARAMETRIC METHODS
    Vatasescui, Anca
    Enache, Florin
    Mircioiu, Constantin
    Miron, Dalia Simona
    Sandulovici, Roxana
    [J]. FARMACIA, 2011, 59 (02) : 161 - 171
  • [48] BASELINE CORRECTION IN BIOEQUIVALENCE STUDIES FOR DRUG PRODUCTS CONTAINING AN ENDOGENOUS COMPOUND.
    Lim, H.
    Sun, W.
    Kim, M.
    Lee, S.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S32 - S33
  • [49] CONTROVERSIES IN BIOEQUIVALENCE STUDIES
    STEINIJANS, VW
    HAUSCHKE, D
    JONKMAN, JHG
    [J]. CLINICAL PHARMACOKINETICS, 1992, 22 (04) : 247 - 253
  • [50] BIOAVAILABILITY AND BIOEQUIVALENCE OF DRUG PRODUCTS
    SPENCER, RL
    [J]. ASSOCIATION OF FOOD & DRUG OFFICIALS QUARTERLY BULLETIN, 1977, 41 (03): : 173 - 178
12345